SC
AZN icon

Schiavi & Co’s AstraZeneca AZN Stock Holding History

Schiavi & Co’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,686
Closed -$770K – 35
2024
Q1 		$770K Hold
5,686
– – 0.3% 11
2023
Q4 		$766K Hold
5,686
– – 0.32% 11
2023
Q3 		$770K Sell
5,686
-50
-0.9% -$6.83K 0.33% 11
2023
Q2 		$821K Hold
5,736
– – 0.34% 11
2023
Q1 		$796K Buy
+5,736
New +$772K 0.34% 11

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Schiavi & Co's AZN Position: Q2 2024 in Review

Schiavi & Co sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 5,686 shares — an estimated $770K sold.

Schiavi & Co first reported a position in AZN in Q1 2023 and held it in 5 quarters. The position peaked at $821K in Q2 2023. 1,212 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

  • Schiavi & Co reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
  • Schiavi & Co sold 5,686 AstraZeneca shares in Q2 2024, an estimated $770K.
  • Schiavi & Co first reported a position in AstraZeneca in Q1 2023 and held it in 5 quarters.
  • Schiavi & Co's AstraZeneca position peaked at $821K in Q2 2023.
  • 1,212 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on Schiavi & Co's 13F filing for Q2 2024, filed 8 Aug 2024.